Product NDC: | 0517-1045 |
Proprietary Name: | Levocarnitine |
Non Proprietary Name: | Levocarnitine |
Active Ingredient(s): | 200 mg/mL & nbsp; Levocarnitine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0517-1045 |
Labeler Name: | American Regent, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075861 |
Marketing Category: | ANDA |
Start Marketing Date: | 20011008 |
Package NDC: | 0517-1045-25 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-1045-25) > 5 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0517-1045-25 |
Proprietary Name | Levocarnitine |
Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-1045-25) > 5 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0517-1045 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levocarnitine |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20011008 |
Marketing Category Name | ANDA |
Labeler Name | American Regent, Inc. |
Substance Name | LEVOCARNITINE |
Strength Number | 200 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Carnitine [Chemical/Ingredient],Carnitine Analog [EPC] |